| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Protara Therapeutics Inc (NASDAQ: TARA)
TARA Technical Analysis
3
| As on 12th Dec 2025 TARA SHARE Price closed @ 5.70 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.00 & Buy for SHORT-TERM with Stoploss of 4.94 we also expect STOCK to react on Following IMPORTANT LEVELS. |
TARASHARE Price
| Open | 6.06 | Change | Price | % |
| High | 6.12 | 1 Day | -0.31 | -5.16 |
| Low | 5.52 | 1 Week | -1.10 | -16.18 |
| Close | 5.70 | 1 Month | 0.56 | 10.89 |
| Volume | 699804 | 1 Year | 2.69 | 89.37 |
| 52 Week High 7.56 | 52 Week Low 2.53 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| OCG | 0.22 | -75.82% |
| NVDA | 175.02 | -3.27% |
| CGC | 1.74 | 53.98% |
| LMDX | 0.02 | 0.00% |
| PLUG | 2.32 | -1.69% |
| YGMZ | 0.02 | -66.67% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| TARA Daily Charts |
TARA Intraday Charts |
Whats New @ Bazaartrend |
TARA Free Analysis |
|
|
TARA Important Levels Intraday
| RESISTANCE | 6.86 |
| RESISTANCE | 6.49 |
| RESISTANCE | 6.26 |
| RESISTANCE | 6.03 |
| SUPPORT | 5.37 |
| SUPPORT | 5.14 |
| SUPPORT | 4.91 |
| SUPPORT | 4.54 |
TARA Forecast December 2025
| 4th UP Forecast | 9.36 |
| 3rd UP Forecast | 8.19 |
| 2nd UP Forecast | 7.46 |
| 1st UP Forecast | 6.74 |
| 1st DOWN Forecast | 4.66 |
| 2nd DOWN Forecast | 3.94 |
| 3rd DOWN Forecast | 3.21 |
| 4th DOWN Forecast | 2.04 |
TARA Weekly Forecast
| 4th UP Forecast | 21.12 |
| 3rd UP Forecast | 16.17 |
| 2nd UP Forecast | 13.12 |
| 1st UP Forecast | 10.06 |
| 1st DOWN Forecast | 1.34 |
| 2nd DOWN Forecast | -1.72 |
| 3rd DOWN Forecast | -4.77 |
| 4th DOWN Forecast | -9.72 |
TARA Forecast2025
| 4th UP Forecast | 21.12 |
| 3rd UP Forecast | 16.17 |
| 2nd UP Forecast | 13.12 |
| 1st UP Forecast | 10.06 |
| 1st DOWN Forecast | 1.34 |
| 2nd DOWN Forecast | -1.72 |
| 3rd DOWN Forecast | -4.77 |
| 4th DOWN Forecast | -9.72 |
Protara Therapeutics Inc ( NASDAQ USA Symbol : TARA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
TARA Business Profile
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chloride, an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease. The company was formerly known as ArTara Therapeutics, Inc. and changed its name to Protara Therapeutics, Inc. in May 2020. Protara Therapeutics, Inc. is headquartered in New York, New York. Address: 345 Park Avenue South, New York, NY, United States, 10010
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service